Showing results (21-30 of 53) with videos related to

Sort By:
Pageof 6
Applied Immunohistochemistry & Molecular Morphology : AIMM|December 4, 2015
BRAFp.V600E, p.V600K, and p.V600R Mutations in Malignant Melanoma: Do They Also Differ in Immunohistochemical Assessment and Clinical Features?Giovanni Ponti, Aldo Tomasi, Antonio Maiorana, et al.
International Journal of Radiation Oncology, Biology, Physics|April 21, 2007
Prognostic and predictive value of baseline and posttreatment molecular marker expression in locally advanced rectal cancer treated with neoadjuvant chemoradiotherapyFederica Bertolini, Carmelo Bengala, Luisa Losi, et al.
European Journal of Cancer (Oxford, England : 1990)|May 15, 2019
Clinical outcomes and prognostic factors in recurrent and/or metastatic head and neck cancer patients treated with chemotherapy plus cetuximab as first-line therapy in a real-world settingRoberta Depenni, Maria Cossu Rocca, Daris Ferrari, et al.
International Journal of Radiation Oncology, Biology, Physics|November 14, 2008
Neoadjuvant treatment with single-agent cetuximab followed by 5-FU, cetuximab, and pelvic radiotherapy: a phase II study in locally advanced rectal cancerFederica Bertolini, Silvana Chiara, Carmelo Bengala, et al.
Journal of Clinical Pathology|March 7, 2013
The somatic affairs of BRAF: tailored therapies for advanced malignant melanoma and orphan non-V600E (V600R-M) mutationsGiovanni Ponti, Giovanni Pellacani, Aldo Tomasi, et al.
Cytometry. Part a : the Journal of the International Society for Analytical Cytology|May 4, 2022
Redistribution of CD8+ T cell subsets in metastatic renal cell carcinoma patients treated with anti-PD-1 therapySara De Biasi, Annalisa Guida, Domenico Lo Tartaro, et al.
Cancer Reports (Hoboken, N.J.)|April 18, 2023
First-line cetuximab + platinum-based therapy for recurrent/metastatic head and neck squamous cell carcinoma: A real-world observational study-ENCOREChristophe Le Tourneau, Massimo Ghiani, Maria Chiara Cau, et al.
Cancer Immunology, Immunotherapy : CII|May 26, 2026
Enterotype-specific microbial biomarkers of immune checkpoint inhibitor response revealed by large-scale integrated metagenomic analysisFrancesco Candeliere, Enrico Busi, Sara Cerri, et al.
Frontiers in Digital Health|April 27, 2026
Preparing real-world data through common data model harmonization of cancer patient records in the COMNet platform at the Modena Oncology CenterLuca Moscetti, Enrico Calanchi, Elisa Pettorelli, et al.
Head & Neck|April 11, 2023
Oropharyngeal squamous cell carcinoma: Prognostic factors for development of distant metastases and oncological outcomesFrancesco Mattioli, Alfredo Lo Manto, Matteo Miglio, et al.
Pageof 6